Novo Nordisk A/S
Copenhagen : NOVO B

August 31, 2012 15:16 ET

Novo Nordisk A/S: Insulin Degludec Passed the Review by the First Committee on Drugs of Pharmaceutical Affairs in Japan

BAGSVAERD, DENMARK--(Marketwire - Aug 31, 2012) - Company Announcement No 54 2012:

This announcement is distributed by Thomson Reuters on behalf of Thomson Reuters clients. The owner of this announcement warrants that:

(i) the releases contained herein are protected by copyright and other applicable laws; and

(ii) they are solely responsible for the content, accuracy and originality of the information contained therein.

Source: Novo Nordisk A/S via Thomson Reuters ONE [HUG#1638160]

Contact Information

  • Novo Nordisk A/S
    Novo Alle , DK-2880 Bagsvaerd, Danmark
    T. Tlf. +45 44 44 88 88
    F. Fax +45 44 44 49 05